Literature DB >> 10051484

Changes in the localization of the rat canalicular conjugate export pump Mrp2 in phalloidin-induced cholestasis.

D Rost1, J Kartenbeck, D Keppler.   

Abstract

Administration of phalloidin, one of the toxic peptides of the mushroom Amanita phalloides, leads to rapid and sustained cholestasis in rats. Although attributed to the interaction of phalloidin with microfilaments, the events leading to cholestasis are incompletely understood. The adenosine triphosphate (ATP)-dependent, apical conjugate export pump, termed multidrug resistance protein 2 (Mrp2) or canalicular multispecific organic anion transporter, is the major driving force for bile salt-independent bile flow. We investigated the role of Mrp2 in phalloidin-induced cholestasis. Bile flow decreased to 53% and 31% of control at 15 and 30 minutes after phalloidin (0.5 mg/kg), respectively. Mrp2-mediated [3H]leukotriene excretion into bile during the initial 45 minutes was reduced to 44% of control when [3H]LTC4 was injected 15 minutes after phalloidin treatment. Mrp2 was progressively lost from the hepatocyte canalicular membrane and detected predominantly on intracellular membrane structures together with other canalicular proteins including P-glycoproteins, ecto-ATPase, and dipeptidyl-peptidase IV. By contrast, structures involved in intercellular adhesion (zonula occludens, zonula adhaerens, and desmosomes) as well as intermediate filaments of the cytokeratin type appeared largely unaffected within 30 minutes after phalloidin. In line with the immunofluorescence analysis, immunoblots indicated a loss of Mrp2 and P-glycoproteins from the canalicular membrane and a 3- and 4.6-fold increase of these transport proteins in the microsomal fraction, respectively. Our results indicate that phalloidin induces marked alterations of the hepatocyte canalicular architecture and a loss of Mrp2 together with other proteins from the canalicular membrane. The resulting cholestasis can therefore be explained in part by the loss of export pumps, including Mrp2, from the canalicular membrane.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10051484     DOI: 10.1002/hep.510290319

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  17 in total

Review 1.  Drug transporters in pharmacokinetics.

Authors:  Ernst Petzinger; Joachim Geyer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-03-11       Impact factor: 3.000

Review 2.  Apical/basolateral surface expression of drug transporters and its role in vectorial drug transport.

Authors:  Kousei Ito; Hiroshi Suzuki; Toshiharu Horie; Yuichi Sugiyama
Journal:  Pharm Res       Date:  2005-09-22       Impact factor: 4.200

3.  Regulation of multidrug resistance-associated protein 2 by calcium signaling in mouse liver.

Authors:  Laura N Cruz; Mateus T Guerra; Emma Kruglov; Albert Mennone; Celia R S Garcia; Ju Chen; Michael H Nathanson
Journal:  Hepatology       Date:  2010-07       Impact factor: 17.425

4.  Electron-microscopic demonstration of multidrug resistance protein 2 (Mrp2) retrieval from the canalicular membrane in response to hyperosmolarity and lipopolysaccharide.

Authors:  F Dombrowski; R Kubitz; A Chittattu; M Wettstein; N Saha; D Häussinger
Journal:  Biochem J       Date:  2000-05-15       Impact factor: 3.857

5.  Radixin is required to maintain apical canalicular membrane structure and function in rat hepatocytes.

Authors:  Wei Wang; Carol J Soroka; Albert Mennone; Christoph Rahner; Kathy Harry; Marc Pypaert; James L Boyer
Journal:  Gastroenterology       Date:  2006-09       Impact factor: 22.682

6.  Pro-hepcidin: expression and cell specific localisation in the liver and its regulation in hereditary haemochromatosis, chronic renal insufficiency, and renal anaemia.

Authors:  H Kulaksiz; S G Gehrke; A Janetzko; D Rost; T Bruckner; B Kallinowski; W Stremmel
Journal:  Gut       Date:  2004-05       Impact factor: 23.059

7.  Impaired localisation and transport function of canalicular Bsep in taurolithocholate induced cholestasis in the rat.

Authors:  F A Crocenzi; A D Mottino; E J Sánchez Pozzi; J M Pellegrino; E A Rodríguez Garay; P Milkiewicz; M Vore; R Coleman; M G Roma
Journal:  Gut       Date:  2003-08       Impact factor: 23.059

Review 8.  Dynamic localization of hepatocellular transporters in health and disease.

Authors:  Marcelo G Roma; Fernando A Crocenzi; Aldo D Mottino
Journal:  World J Gastroenterol       Date:  2008-11-28       Impact factor: 5.742

9.  Canalicular membrane MRP2/ABCC2 internalization is determined by Ezrin Thr567 phosphorylation in human obstructive cholestasis.

Authors:  Jin Chai; Shi-Ying Cai; Xiaocong Liu; Wei Lian; Sheng Chen; Liangjun Zhang; Xinchan Feng; Ying Cheng; Xiaochong He; Yu He; Lei Chen; Rongquan Wang; Huaizhi Wang; James L Boyer; Wensheng Chen
Journal:  J Hepatol       Date:  2015-07-23       Impact factor: 25.083

10.  Characterization of the transport of the bicyclic peptide phalloidin by human hepatic transport proteins.

Authors:  Thomas Fehrenbach; Yunhai Cui; Heinz Faulstich; Dietrich Keppler
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-10-03       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.